Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson
Jan 18, 2024, 11:27 |
Insight
Hagop Kantarjian: Hyper-CVD + venetoclax achieves CR/CRi rate of 57% in heavily treated relapsed/refractory Acute Lymphoblastic Leukemia
Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson…
Jan 16, 2024, 17:27 |
Positive
Naveen Pemmaraju: A place of hope
Naveen Pemmaraju shared on X/Twitter: "MD Anderson Cancer Center is a place of inspiration. A…
Jan 16, 2024, 11:37 |
Insight
Jayastu Senapati: Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Jan 15, 2024, 14:11 |
Blog
Jennifer R Wang: Higher germline genetic risk in papillary thyroid cancer is associated with higher odds of having a BRAF-mutated tumor
Jennifer R Wang, Assistant Professor at MD Anderson Cancer Center, shared a post on X/Twitter: "Check…
Jan 15, 2024, 13:28 |
Insight
Shubham Pant: Phase 1 AMPLIFY-201 trial
Shubham Pant, Professor, Department of Gastrointestinal (GI) Medical Oncology and Investigational Cancer Therapeutics, Division of…
Jan 14, 2024, 18:08 |
Blog
Vivek Subbiah: The 1st report from the Cancer Programme of the Genomes 100k project
Vivek Subbiah posted on X/Twitter: "Just out Nature Medicine: The 1st report from the Cancer Programme…
Jan 14, 2024, 15:04 |
Opinion
Eric Singhi: As a physician of color born in the USA, this ‘compliment’ was uncomfortable
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared on X/Twitter: "'You…
Jan 14, 2024, 10:02 |
Insight
Vivek Subbiah: Nature Reviews predicts a doubling of the incidence of all cancers combined by 2070 relative to 2020
Vivek Subbiah shared on LinkedIn: "Assuming that the latest incidence trends continue for the major…
Jan 12, 2024, 22:39 |
Blog
Vivek Subbiah: Optimizing anti–body drug conjugates and radiopharmaceuticals for precision therapy
Vivek Subbiah shared a post on LinkedIn: “Sharing this editorial from 2021: Optimizing anti–body drug conjugates…
Jan 12, 2024, 11:04 |
Career
Felicia Nica: I am going back to working in regulatory affairs - this time at Baylor College of Medicine
Felicia Nica, Director of Regulatory Affairs at Baylor College of Medicine, shared on LinkedIn: "With…
133
134
135
136
137
All:
1560
Posts:
1341 - 1350
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube